Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

RWE Study Utilizing the Cala Trio Device in Patients With Essential Tremor

NCT: NCT05540626 · COMPLETED

NCT IDNCT05540626
StatusCOMPLETED
Start Date2021-04-08
Completion2024-03-01
SponsorCala Health, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

The study objective is to evaluate hand tremor relief in the treated hand following stimulation with the Cala Trio Device in adults with essential tremor, and healthcare resource utilization and total healthcare costs over a 12-month period.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑